Drug therapy for hereditary cancers

por Imyanitov, Evgeny N, Moiseyenko, Vladimir M
Publicado 2011

Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation

por Moiseyenko, Fedor V., Egorenkov, Vitaliy V., Kramchaninov, Mikhail M., Artemieva, Elizaveta V., Aleksakhina, Svetlana N., Holmatov, Maxim M., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.
Publicado 2019

“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion

por Moiseyenko, Vladimir M, Chubenko, Vyacheslav A, Moiseyenko, Fedor V, Zagorskaya, Lyudmila A, Zaytseva, Yuliya A, Gesha, Nataliya E, Zykov, Evgeny N, Ni, Valeriya I, Preobrazhenskaya, Elena V, Sokolenko, Anna P, Imyanitov, Evgeny N
Publicado 2018

Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Brea...

por Sokolenko, Anna P., Moiseyenko, Fedor V., Iyevleva, Aglaya G., Ivantsov, Alexandr O., Dolmatov, Georgiy D., Shelekhova, Ksenia V., Gulo, Elizaveta V., Topal, Anastasya X., Artemieva, Elizaveta V., Abduloeva, Nuriniso H., Rysev, Nikita A., Barsova, Daria A., Levchenko, Natalia V., Volkov, Nikita M., Egorenkov, Vitaliy V., Moiseyenko, Vladimir M., Imyanitov, Evgeny N.
Publicado 2023